Radiopharm Theranostics Ltd. (Form 6-K)
This Form 6-K, filed for November 2025, serves to incorporate two material announcements previously published to the ASX on November 3, 2025.
Key Investor Updates:
- Director Activity: Disclosure of a Change of Director’s Interest Notice (RC), indicating potential insider holdings movement.
- Investor Relations: The Company is scheduled for a presentation at the Deutsche Bank ADR Virtual Investor Conference.
...Investors should examine Exhibits 99.1 and 99.2 for the full context of the Director’s interest filing and the investor pre